UBS Group’s Kronos Bio KRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,012
Closed -$1.91K 10496
2024
Q4
$1.91K Buy
+2,012
New +$1.9K ﹤0.01% 9144
2024
Q2
Sell
-20,645
Closed -$26.8K 9834
2024
Q1
$26.8K Buy
+20,645
New +$23.5K ﹤0.01% 6782
2023
Q4
Sell
-100
Closed -$130 9624
2023
Q3
$130 Buy
+100
New +$162 ﹤0.01% 8824
2023
Q2
Sell
-15,091
Closed -$22K 9298
2023
Q1
$22K Buy
15,091
+4,166
+38% +$7.99K ﹤0.01% 7012
2022
Q4
$17.7K Buy
10,925
+10,891
+32,032% +$25.1K ﹤0.01% 7805
2022
Q3
$0 Buy
+34
New +$153 ﹤0.01% 10648
2022
Q2
Sell
-93,236
Closed -$674K 10645
2022
Q1
$674K Buy
93,236
+46,940
+101% +$400K ﹤0.01% 4458
2021
Q4
$629K Buy
46,296
+44,000
+1,916% +$688K ﹤0.01% 4790
2021
Q3
$48K Buy
2,296
+200
+10% +$4.3K ﹤0.01% 6368
2021
Q2
$50K Buy
2,096
+93
+5% +$2.35K ﹤0.01% 6431
2021
Q1
$59K Sell
2,003
-302
-13% -$8.85K ﹤0.01% 6374
2020
Q4
$69K Buy
+2,305
New +$72.3K ﹤0.01% 5931

Other funds holding KRON